Marburg virus - the next pandemic?

<p>In August 1967, laboratory workers in the West German towns of Marburg and Frankfurt began falling ill with a mysterious haemorrhagic fever, and within days two more cases appeared in Belgrade, then part of Yugoslavia. Twenty-five people were infected directly and seven died. The common thread was a shipment of African green monkeys imported from Uganda for vaccine production — a shipment that, because of the Six-Day War fought that June, had been rerouted through London and held in animal storage during an airport strike. From that accident of geopolitics came the first recorded appearance of the virus now named after the German university town where it was identified: Marburg. Half a century on, it remains one of the deadliest pathogens known, and the question of whether it could seed a pandemic is worth answering carefully rather than luridly.</p> <h2 id="what-marburg-actually-is">What Marburg actually is</h2><div class="ad-unit ad-in-article" aria-label="Advertisement"> <span class="ad-label">Advertisement</span> <ins class="adsbygoogle" style="display:block;text-align:center" data-ad-client="ca-pub-3726833845844946" data-ad-slot="3291553914" data-ad-format="auto" data-full-width-responsive="true"></ins> <script>(adsbygoogle = window.adsbygoogle || []).push({});</script> </div> <p>Marburg virus is a filovirus — a thread-shaped, negative-sense single-stranded RNA virus — and the same family that includes Ebola. The disease it causes, Marburg virus disease, produces severe multi-organ dysfunction and, in some outbreaks, external and internal bleeding. It is not, despite the reputation, primarily a &ldquo;bleed from every orifice&rdquo; illness; haemorrhage appears in a minority of cases, and death more often comes from shock and organ failure. The World Health Organization records case-fatality ratios ranging from roughly 24 per cent in the original 1967 European outbreak to as high as 88 per cent in some later African outbreaks, with the average sitting around 50 per cent. That spread reflects how much survival depends on early, intensive supportive care rather than on the virus alone.</p> <p>Crucially, and this is where careful language matters, there is at present no licensed vaccine and no approved specific antiviral treatment for Marburg. Care is supportive: rehydration, maintenance of blood pressure and oxygen, and treatment of secondary infections. Several vaccine candidates and monoclonal-antibody therapies are in development, and the same platform technologies that produced Ebola vaccines are being turned toward Marburg, but as of the mid-2020s none has completed the path to routine use.</p> <h2 id="history">History</h2> <p>The 1967 outbreak is unusually well documented because it happened inside the vaccine industry. The Marburg patients worked at Behringwerke, a producer of sera and vaccines; the Frankfurt patients at the Paul Ehrlich Institute, which tested them; the Belgrade case in a facility handling live vaccines. All had contact with the blood, organs or cell cultures of grivets — a species of African green monkey — whose kidney cells were being used to manufacture and safety-test polio vaccine. Researchers later traced the source to infected monkeys imported from Uganda. The wartime rerouting of that shipment through London is the sort of detail that reads like fiction but is drawn directly from the epidemiological record.</p> <p>The natural reservoir turned out to be not primates but bats. The Egyptian rousette fruit bat, <em>Rousettus aegyptiacus</em>, is now understood to carry Marburg virus without necessarily falling ill, and human outbreaks have repeatedly been linked to caves and mines where these bats roost. The largest known outbreak struck Angola in 2004–2005, centred on the northern province of Uige, where at least 227 of the roughly 252 recorded cases died — a fatality rate approaching 90 per cent, worsened by transmission inside hospitals. An outbreak in the Democratic Republic of Congo between 1998 and 2000, tied to a gold mine at Durba, killed most of those it infected. More recent flare-ups in Equatorial Guinea and Tanzania in 2023, and in Rwanda in 2024, showed that the virus continues to emerge, and that faster detection and case isolation can now contain it before it spreads widely.</p> <h2 id="why-it-matters">Why it matters</h2><div class="ad-unit ad-in-article" aria-label="Advertisement"> <span class="ad-label">Advertisement</span> <ins class="adsbygoogle" style="display:block;text-align:center" data-ad-client="ca-pub-3726833845844946" data-ad-slot="3291553914" data-ad-format="auto" data-full-width-responsive="true"></ins> <script>(adsbygoogle = window.adsbygoogle || []).push({});</script> </div> <p>Marburg matters not because it is likely to cause the next great pandemic, but because it sits at the intersection of the traits that make a pathogen dangerous and the ones that, mercifully, limit it. It is extraordinarily lethal and has no vaccine — those are the frightening facts. But it does not spread through the air the way an influenza or a coronavirus does. Transmission requires direct contact with the blood or bodily fluids of a symptomatic person, or with contaminated surfaces and equipment. People are not meaningfully infectious before they show symptoms. That biology is the reason Marburg has produced terrifying local outbreaks but never a global one.</p> <p>The honest verdict, then, is that a naturally emerging Marburg pandemic is unlikely — but &ldquo;unlikely&rdquo; is not &ldquo;impossible&rdquo;, and the margin depends entirely on public-health infrastructure. The 2004 Angola outbreak became catastrophic partly because it spread inside under-resourced hospitals through reused needles and inadequate barrier nursing. The same virus, met with rapid contact-tracing and isolation, was stopped in Rwanda in 2024 with a far lower toll. The difference was not the pathogen but the response, which is the most important lesson the virus has to teach.</p> <h2 id="how-outbreaks-are-handled">How outbreaks are handled</h2> <p>Containing a Marburg outbreak follows the hard-won filovirus playbook refined during West Africa&rsquo;s 2014–2016 Ebola epidemic. The core actions are rapid case identification, isolation of the sick, meticulous contact-tracing of everyone exposed, safe and dignified burial practices — because the bodies of the dead are highly infectious, a genuine danger during traditional funeral washing — and strict infection control in clinics, including full personal protective equipment for health workers. Health workers themselves are among the most vulnerable, and outbreaks have repeatedly killed the very doctors and nurses treating the first cases before the cause is understood.</p> <p>Where Marburg differs from many diseases is that prevention cannot yet lean on immunisation. This is a striking contrast to a threat like tetanus, where a reliable vaccine turned a common killer into a rare tragedy — the arc traced in the story of <a href="/story/the-tetanus-vaccine-a-triumph-of-modern-medicine/">the tetanus vaccine as a triumph of modern medicine</a>. Marburg has no such shield in routine use, which is precisely why the surveillance-and-isolation approach carries the whole weight of the defence.</p> <p>The response also depends on unglamorous logistics that outbreaks in remote regions make difficult. Diagnosing Marburg requires laboratory confirmation, and the specialised assays that distinguish it from Ebola or from ordinary tropical fevers are not available in every district clinic. Samples must be handled at high biosafety levels and often shipped to reference laboratories, introducing delay at exactly the moment when speed decides how far a cluster spreads. When Rwanda contained its 2024 outbreak quickly, it did so partly because testing capacity and trained response teams were already in place — a reminder that the defence against a pathogen this lethal is built during the quiet years, not improvised during the crisis. The same shortfalls that let the Angola outbreak run out of control in 2005 were, at root, failures of preparation rather than of medicine. In Uige, transmission was amplified inside hospitals through reused syringes and the absence of protective equipment, so that health facilities became engines of spread rather than places of containment. Community mistrust made it worse: families who saw relatives taken to clinics and returned as corpses understandably hid the sick and continued traditional burials, defeating the very isolation the response depended on. Winning that trust — explaining, rather than merely imposing, safe burial and case isolation — turned out to be as decisive as any medical intervention, and it is a lesson every subsequent filovirus response has had to relearn.</p> <h2 id="fun-facts">Fun facts</h2> <ul> <li>Marburg and Ebola are close cousins in the filovirus family, but Marburg was actually identified first — in 1967, nine years before Ebola was described in 1976.</li> <li>The virus&rsquo;s arrival in Europe was an accident of war: the fateful monkey shipment was diverted through London because the Six-Day War disrupted the usual route from Uganda to Frankfurt.</li> <li>The animal reservoir is not the monkeys blamed in 1967 but the Egyptian fruit bat, and several outbreaks have been traced to people entering bat-infested caves and mines.</li> <li>One tourist who visited a python cave in Uganda in 2008 carried Marburg home to the Netherlands, where she died — a rare case of the virus travelling to a wealthy country.</li> <li>Despite its ferocity, Marburg has never caused sustained person-to-person spread outside a cluster, because a patient becomes infectious only once symptoms appear, not before.</li> </ul> <h2 id="a-closing-reflection">A closing reflection</h2> <p>The instinct to ask whether Marburg is &ldquo;the next pandemic&rdquo; says more about how we think about risk than about the virus. We are drawn to lethality as the measure of danger, but a pathogen&rsquo;s threat is a product of how deadly it is <em>and</em> how easily it moves, and Marburg scores high on one and low on the other. The diseases that actually reshape the world tend to be the ones that spread quietly and kill modestly, not the ones that kill dramatically and spread with difficulty. It is a smaller-scale version of the reasoning behind every serious look at <a href="/story/earths-next-mass-extinction/">Earth&rsquo;s next mass extinction</a>: the events most likely to do catastrophic damage are rarely the ones that make the most vivid headlines. The mature reason to keep watching Marburg is not that it will inevitably escape, but that the systems built to contain it — the surveillance networks, the outbreak teams, the eventual vaccine — are the same systems that will decide how badly the next genuinely airborne threat hurts us. Preparing for the frightening virus that probably will not come is how you get ready for the ordinary one that will.</p>